ClinicalTrials.Veeva

Menu

Quantitative Renal Uptake Using TC99m DMSA in Hypertensive &/or Diabetic Patients.

A

Assiut University

Status and phase

Unknown
Phase 4

Conditions

Hypertension
Diabetes Mellitus

Treatments

Diagnostic Test: DMSA scan

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

the investigators explore the possible role of DMSA to detect renal affection in diabetic &/or hypertensive patients by detecting difference in counts using Tc 99m DMSA in control & diabetic &/or hypertensive patients.

Enrollment

45 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • Patients with diabetes (type2), weather controlled or not.

    • Patients with essential hypertension.
    • Patients with diabetes & hypertension.
    • Within normal renal function (urea & creatinine).
    • Control cases may be normal individuals (apparently healthy) like donors for renal transplant.

Exclusion criteria

  • • Patients with abnormal renal function.

    • Patients with diseases known to affect kidney function rather diabetes & hypertension e.g. SLE, heart failure or liver cell failure.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

45 participants in 4 patient groups, including a placebo group

Control
Placebo Comparator group
Description:
control will be subjected to: • Quantitative Tc99m DMSA renal scan using SPECT technique.
Treatment:
Diagnostic Test: DMSA scan
Diabetic
Active Comparator group
Description:
diabetic cases will be subjected to: • Quantitative Tc99m DMSA renal scan using SPECT technique.
Treatment:
Diagnostic Test: DMSA scan
Hypertensive
Active Comparator group
Description:
hypertesive cases will be subjected to: • Quantitative Tc99m DMSA renal scan using SPECT technique.
Treatment:
Diagnostic Test: DMSA scan
Diabetic & Hypertensive
Active Comparator group
Description:
Diabetic \& Hypertensive cases will be subjected to: • Quantitative Tc99m DMSA renal scan using SPECT technique.
Treatment:
Diagnostic Test: DMSA scan

Trial contacts and locations

1

Loading...

Central trial contact

Heba Askar, MsC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems